Ferritin Complex Vaccine against Influenza A Using Screened Immunogenic Sequences from Fv-Antibody Library

IF 3.7 Q1 CHEMISTRY, MEDICINAL
ACS Pharmacology and Translational Science Pub Date : 2026-10-09 Epub Date: 2026-09-16 DOI:10.1021/acsptsci.6c00419
Tae-Hun Kim, Soonil Kwon, Jaeyong Jung, Jeong Soo Sung, Dong-Ho Han, Min-Jung Kang, Joachim Jose, Misu Lee, Jae-Chul Pyun
{"title":"Ferritin Complex Vaccine against Influenza A Using Screened Immunogenic Sequences from Fv-Antibody Library","authors":"Tae-Hun Kim,&nbsp;Soonil Kwon,&nbsp;Jaeyong Jung,&nbsp;Jeong Soo Sung,&nbsp;Dong-Ho Han,&nbsp;Min-Jung Kang,&nbsp;Joachim Jose,&nbsp;Misu Lee,&nbsp;Jae-Chul Pyun","doi":"10.1021/acsptsci.6c00419","DOIUrl":null,"url":null,"abstract":"<p>A ferritin-based influenza A vaccine was developed. The\r\nimmunogenic\r\nsequences of the nucleoprotein (NP) were screened using an autodisplayed\r\nFv-antibody library, and the paratopes with a high-affinity binding\r\naffinity were analyzed through docking simulations. The resulting\r\nantigenic sequences were engineered into single-domain constructs\r\nusing a nonimmunogenic linker. These immunogenic sequences were then\r\nexpressed in conjunction with ferritin heavy-chain proteins to form\r\nspherical nanoparticles through self-assembly. These NP-ferritin complex\r\nvaccines were subsequently injected into mice, and antibody responses,\r\ncytokine secretion, and T-cell activation profiles were subsequently\r\nanalyzed to demonstrate that the ferritin-based NP vaccines activated\r\ninnate as well as acquired immune responses.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"9 10","pages":"2939–2949"},"PeriodicalIF":3.7000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsptsci.6c00419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

A ferritin-based influenza A vaccine was developed. The immunogenic sequences of the nucleoprotein (NP) were screened using an autodisplayed Fv-antibody library, and the paratopes with a high-affinity binding affinity were analyzed through docking simulations. The resulting antigenic sequences were engineered into single-domain constructs using a nonimmunogenic linker. These immunogenic sequences were then expressed in conjunction with ferritin heavy-chain proteins to form spherical nanoparticles through self-assembly. These NP-ferritin complex vaccines were subsequently injected into mice, and antibody responses, cytokine secretion, and T-cell activation profiles were subsequently analyzed to demonstrate that the ferritin-based NP vaccines activated innate as well as acquired immune responses.

从fv抗体文库中筛选免疫原性序列抗甲型流感铁蛋白复合物疫苗
研制了一种基于铁蛋白的甲型流感疫苗。利用自动显示的fv抗体文库筛选核蛋白(NP)的免疫原性序列,并通过对接模拟分析具有高亲和力结合亲和力的paratopes。所得到的抗原序列利用非免疫原性连接体被设计成单域结构。这些免疫原性序列随后与铁蛋白重链蛋白结合表达,通过自组装形成球形纳米颗粒。这些NP-铁蛋白复合物疫苗随后被注射到小鼠体内,抗体反应、细胞因子分泌和t细胞活化谱随后被分析,以证明基于铁蛋白的NP疫苗激活了获得性和获得性免疫反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Pharmacology and Translational Science
ACS Pharmacology and Translational Science Medicine-Pharmacology (medical)
CiteScore
10.00
自引率
3.30%
发文量
133
期刊介绍: ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered. ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition. Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书